These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 36853660)

  • 1. CRISPR-Cas9-mediated insertion of a short artificial intron for the generation of conditional alleles in mice.
    Cassidy A; Pelletier S
    STAR Protoc; 2023 Mar; 4(1):102116. PubMed ID: 36853660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-step generation of a conditional allele in mice using a short artificial intron.
    Cassidy AM; Thomas DB; Kuliyev E; Chen H; Pelletier S
    Heliyon; 2022 Dec; 8(12):e12630. PubMed ID: 36619446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-step CRISPR-Cas9 protocol for the generation of plug & play conditional knockouts in
    Yu JJS; Vincent JP; McGough IJ
    STAR Protoc; 2021 Jun; 2(2):100560. PubMed ID: 34095868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A small cassette enables conditional gene inactivation by CRISPR/Cas9.
    Guzzardo PM; Rashkova C; Dos Santos RL; Tehrani R; Collin P; Bürckstümmer T
    Sci Rep; 2017 Dec; 7(1):16770. PubMed ID: 29196747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protocol for gene characterization in Aspergillus niger using 5S rRNA-CRISPR-Cas9-mediated Tet-on inducible promoter exchange.
    Zheng X; Cairns T; Zheng P; Meyer V; Sun J
    STAR Protoc; 2022 Dec; 3(4):101838. PubMed ID: 36595926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/Cas9-mediated tissue-specific knockout and cDNA rescue using sgRNAs that target exon-intron junctions in
    Chilian M; Vargas Parra K; Sandoval A; Ramirez J; Yoon WH
    STAR Protoc; 2022 Sep; 3(3):101465. PubMed ID: 35719725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protocol for the saturation and multiplexing of genetic variants using CRISPR-Cas9.
    Sahu S; Sullivan T; Southon E; Caylor D; Geh J; Sharan SK
    STAR Protoc; 2023 Dec; 4(4):102702. PubMed ID: 37948185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of epitope tag knock-in mice with CRISPR-Cas9 to study the function of endogenous proteins.
    Zhang Z
    STAR Protoc; 2023 Sep; 4(3):102518. PubMed ID: 37585297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protocol for generating in-frame seamless knockins in Drosophila using the SEED/Harvest technology.
    Aguilar G; Bauer M; Vigano MA; Guerrero I; Affolter M
    STAR Protoc; 2024 Sep; 5(3):102932. PubMed ID: 38996063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute gene inactivation in the adult mouse liver using the CRISPR-Cas9 technology.
    Wang X; Xu BL; Chen XW
    STAR Protoc; 2021 Sep; 2(3):100611. PubMed ID: 34189476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting endogenous proteins for spatial and temporal knockdown using auxin-inducible degron in Caenorhabditis elegans.
    Kurashina M; Mizumoto K
    STAR Protoc; 2023 Mar; 4(1):102028. PubMed ID: 36640369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protocol for CRISPR-Cas9-mediated genome editing to study spermatogenesis in Caenorhabditis elegans.
    Wang P; Cao Z; Wang Q; Ma X; Wang N; Chen L; Zhao Y; Miao L
    STAR Protoc; 2023 Dec; 4(4):102720. PubMed ID: 37967017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimized protocols for efficient gene editing in mouse hepatocytes
    Chen Y; Ding Q
    STAR Protoc; 2022 Mar; 3(1):101062. PubMed ID: 35005644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiplexed CRISPR-Cas9 protocol for large transgene integration into the Schistosoma mansoni genome.
    Ittiprasert W; Moescheid MM; Mann VH; Brindley PJ
    STAR Protoc; 2024 Mar; 5(1):102886. PubMed ID: 38354082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of mouse models carrying B cell restricted single or multiplexed loss-of-function mutations through CRISPR-Cas9 gene editing.
    Ten Hacken E; Gruber M; Hernández-Sánchez M; Hoffmann GB; Baranowski K; Redd RA; Clement K; Livak K; Wu CJ
    STAR Protoc; 2023 Dec; 4(4):102165. PubMed ID: 37729058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimized protocol to create deletion in adherent cell lines using CRISPR/Cas9 system.
    Farooq U; Notani D
    STAR Protoc; 2021 Dec; 2(4):100857. PubMed ID: 34746853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SCON-a Short Conditional intrON for conditional knockout with one-step zygote injection.
    Wu SS; Lee H; Szép-Bakonyi R; Colozza G; Boese A; Gert KR; Hallay N; Lee JH; Kim J; Zhu Y; Linssen MM; Pilat-Carotta S; Hohenstein P; Theussl HC; Pauli A; Koo BK
    Exp Mol Med; 2022 Dec; 54(12):2188-2199. PubMed ID: 36494589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protocol to efficiently induce CRISPR-Kill-mediated cell ablation in Arabidopsis thaliana.
    Gehrke F; Wolf S; Puchta H
    STAR Protoc; 2024 Jun; 5(2):103072. PubMed ID: 38768032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimized CRISPR/Cas9-mediated single nucleotide mutation in adherent cancer cell lines.
    Gao P; Dong X; Wang Y; Wei GH
    STAR Protoc; 2021 Jun; 2(2):100419. PubMed ID: 33870225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protocol for efficient CRISPR-Cas9-mediated fluorescent tag knockin in hard-to-transfect erythroid cell lines.
    Deleuze V; Soler E; Andrieu-Soler C
    STAR Protoc; 2024 Jun; 5(2):103016. PubMed ID: 38640065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.